Online Program

339459
Implications and Lessons learned from the Transportation and Health Tool


Monday, November 2, 2015 : 9:20 a.m. - 9:35 a.m.

Kate Robb, MSPH, Center for Public Health Policy, APHA, Washington, DC
With the release of the innovative Transportation and Health Tool (THT), communities will have the power to discern leading health and transportation indicators. This presentation will discuss the value of the tool for the transportation and public health sectors, demonstrating how public health goals can be incorporated into transportation plans, policies, and programs. Examples of how the THT can be used by communities will offer insight into the tool’s implications for public health practitioners working in the intersection of these sectors.  Armed with the specific data from their communities and evidence-based policies, strategies and interventions to address health, practitioners can strategically build and strengthen partnerships between the transportation and health sectors.  Lastly, the presentation will discuss the dissemination strategy of the THT to provide attendees with next steps and accessibility of the THT.

Learning Areas:

Environmental health sciences
Program planning
Public health or related public policy

Learning Objectives:
Explain the value and implications of the THT on the transportation and health sectors.

Keyword(s): Transportation

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: I am a policy analyst at the American Public Health Association, working on the Healthy Community Design initiatives for the Center for Public Health Policy. This work includes active transportation, transportation, and healthy homes. I have expertise in community engagement, chronic disease prevention initiatives, & promoting walkability on a local level. I received my MSPH from Johns Hopkins Bloomberg School of Public Health & a BS in Environmental & Plant Biology from Ohio University.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.